# A Study to Evaluate the Use of Placenta Protein 13 (PP13) in the First Trimester of Pregnancy as a Diagnostic Aiding Tool in the Assessment of the Risk for Developing Preeclampsia in Women With Low and Unknown Risk

> **NCT00572793** · — · COMPLETED · sponsor: **Carl Weiner, MD** · enrollment: 431 (actual)

## Conditions studied

- Preeclampsia

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT00572793
- **Lead sponsor:** Carl Weiner, MD
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2007-11
- **Primary completion:** 2014-07
- **Final completion:** 2014-07
- **Target enrollment:** 431 (ACTUAL)
- **Last updated:** 2015-07-08

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00572793

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00572793, "A Study to Evaluate the Use of Placenta Protein 13 (PP13) in the First Trimester of Pregnancy as a Diagnostic Aiding Tool in the Assessment of the Risk for Developing Preeclampsia in Women With Low and Unknown Risk". Retrieved via AI Analytics 2026-08-11 from https://api.ai-analytics.org/clinical/NCT00572793. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*